H6D0:ETR
Haleon PLC
€4.07
arrow_upward
+0.32%(+0.013) 1D
Oct 8, 1:17:46 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for H6D0...
Open
€4.02
High
€4.08
Low
€4.02
Mkt. cap
29.62B
Avg. vol.
19.14K
Volume
612.00
52-wk high
€4.78
52-wk low
€3.72
No. of employees
25K
Open
€4.02
High
€4.08
Low
€4.02
Mkt. cap
29.62B
Avg. vol.
19.14K
Volume
612.00
52-wk high
€4.78
52-wk low
€3.72
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
JPMorgan cuts target for Haleon stock to GBp 295
AD HOC NEWS
·
2 days ago
JPMorgan cuts target for Haleon stock to GBp 295.00
Kalkine Media
·
2 days ago
Why Is Haleon (LSE:HLN) Stock Slipping Today As Growth Worries Build Ahead Of Its Update?
AD HOC NEWS
·
2 days ago
Haleon stock faces a 295 GBp JPMorgan target cut
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC